ghk cu or glow Blend – 70 mg (GHK-CU + BPC-157 + TB-500) – BioPeptics GLOW Blend | BPC-157 TB-500

But the people making the claim are not cranks

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions

Medically Reviewed on 5/2/2025 Tabletwise

Well look into some other alternatives, especially since Medicare doesnt cover Wegovy